Scotia Capital’s Johnson & Johnson JNJ Stock Holding History
Bought
Maintained
Sold
Other funds holding JNJ
VCM
VPM
Scotia Capital's JNJ Position: Q1 2026 in Review
Scotia Capital reduced its Johnson & Johnson (JNJ) stake by 6.8% in Q1 2026, selling an estimated $20.8M and leaving 1,231,920 shares worth $301M. The position accounts for 1.24% of the portfolio, ranked #23.
Scotia Capital first reported a position in JNJ in Q2 2013 and has held it in 52 quarters since. 4,616 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.
- Scotia Capital held 1,231,920 shares of Johnson & Johnson worth $301M as of Q1 2026.
- Scotia Capital sold 89,336 Johnson & Johnson shares in Q1 2026, an estimated $20.8M.
- Johnson & Johnson made up 1.24% of Scotia Capital's portfolio in Q1 2026, its #23 holding.
- Scotia Capital first reported a position in Johnson & Johnson in Q2 2013 and has held it in 52 quarters since.
- 4,616 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.
Based on Scotia Capital's 13F filing for Q1 2026, filed 13 May 2026.